Cystic Fibrosis Mutation Detection Test
Test Cost: AED 2110.0
Symptoms, Diagnosis, and Test Details
Are you concerned about cystic fibrosis? DNA Labs UAE offers the Cystic Fibrosis Mutation Detection Test, a genetic test that can identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This test is crucial for individuals with symptoms or a family history of cystic fibrosis.
Test Components and Sample Condition
- Price: AED 2110.0
- Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube OR 10 mL Amniotic fluid in a sterile screw capped container. Ship refrigerated. DO NOT FREEZE.
- Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery and Method
- Report Delivery: Sample Daily by 11 am; Report 6 weeks
- Method: PCR, Sequencing
Test Type and Doctor
- Test Type: Genetic Disorders
- Doctor: Pediatrician, Physician
Test Department and Pre Test Information
- Test Department: MOLECULAR DIAGNOSTICS
- Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
About the Test
The Cystic Fibrosis Mutation Detection Test is a genetic test used to identify mutations in the CFTR gene. The CFTR gene is responsible for producing a protein that regulates the flow of salt and fluids in and out of cells. Mutations in this gene can lead to the development of cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs.
The test involves collecting a sample of DNA, usually through a blood sample or cheek swab, and analyzing it for specific mutations in the CFTR gene. It can detect the most common mutations out of the hundreds known. The results of the test can help diagnose cystic fibrosis in individuals with symptoms or a family history of the condition. It can also be used for carrier screening, determining if an individual carries a mutated CFTR gene and is at risk of passing it on to their children.
Genetic counselors and healthcare providers can interpret the test results and provide appropriate counseling and recommendations based on the individual’s genetic profile. This may include treatment options, management strategies, and family planning considerations.
It is important to note that the Cystic Fibrosis Mutation Detection Test is not a diagnostic tool on its own. It is typically used alongside other clinical evaluations and tests to make a definitive diagnosis of cystic fibrosis or determine carrier status.
| Test Name | CYSTIC FIBROSIS MUTATION DETECTION Test |
|---|---|
| Components | |
| Price | 2110.0 AED |
| Sample Condition | 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube OR 10 mL Amniotic fluid in a sterile screw capped container. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | Sample Daily by 11 am;Report 6 weeks |
| Method | PCR, Sequencing |
| Test type | Genetic Disorders |
| Doctor | Pediatrician, Physician |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details | The Cystic Fibrosis Mutation Detection Test is a genetic test used to identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This gene is responsible for producing a protein that helps regulate the flow of salt and fluids in and out of cells. Mutations in the CFTR gene can lead to the development of cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs. The test involves collecting a sample of DNA, usually through a blood sample or cheek swab, and analyzing it for specific mutations in the CFTR gene. There are hundreds of known mutations in this gene, and the test can detect the most common ones. The results of the test can help diagnose cystic fibrosis in individuals with symptoms or a family history of the condition. It can also be used for carrier screening, which can determine if an individual carries a mutated CFTR gene and is at risk of passing it on to their children. Genetic counselors and healthcare providers can interpret the results of the test and provide appropriate counseling and recommendations based on the individual’s specific genetic profile. This may include treatment options, management strategies, and family planning considerations. It is important to note that the Cystic Fibrosis Mutation Detection Test is not a diagnostic tool on its own. It is typically used in conjunction with other clinical evaluations and tests to make a definitive diagnosis of cystic fibrosis or determine carrier status. |
